MacroGenics (MGNX) said on Monday it agreed to sell its GMP drug substance manufacturing operations to Bora Pharmaceuticals Co., Ltd. for $122.5 million upfront. The deal includes MacroGenics’ manufacturing facilities…
Tag:
